Molecular Tumour Board: Treating acute Myeloid Leukaemia in the genomic era

18 March, 12.30pm - 1.30pm

Maridulu Budyari Gumal (SPHERE) Cancer CAG NSW in collaboration with the Regional Cancer Research Network, and Sydney Cancer Partners is hosting the 2025 NSW Cancer Research Education Statewide Seminar Series. These online seminars will be held on the 3rd Tuesday of each month.

Session Information:
A Molecular Tumour Board (MTB) is a multi-disciplinary forum for discussion, interpretation and communication about molecular results that may have implications for patient care. MTBs often include geneticists, bioinformaticians and molecular biologists in addition to clinical disciplines such as oncology, surgery, radiotherapy and pathology.

The NSW Cancer Research Education Seminar Series educational MTB sessions will include case-based presentations from MTBs working in paediatric and adult cancer. This will be an opportunity to share knowledge across cancer types; sparking new research ideas and fostering collaboration. 

Speakers: 
Dr Lachlin Vaughan, Clinical and laboratory haematologist and the clinical lead for acute leukaemias at Westmead Hospital. He completed a PhD under Prof John Pimanda at the Lowy Cancer Research Centre, UNSW investigating strategies to overcome azacitidine resistance in higher risk myelodysplastic syndromes and acute myeloid leukaemia. He is an active member of the Australian Lymphoma and Leukaemia Group in the Acute Leukaemia Working Group.

Dr Gaurav Sutrave, Staff Specialist Haematologist and a Blood Transplant and Cell Therapies Physician at Westmead Hospital, and the Medical Director for the Westmead T cell Therapies Laboratory. His research interest includes exploring the development of novel adoptive cell therapies for the treatment of infectious complications in immunosuppressed patients.

Session Chair: 
Clinical Professor Rosemary Balleine, Research Pathologist working in the field of translational cancer research. She has long-standing connections to health services and translational research initiatives in western Sydney. Prof Balleine’s research has focused in the areas of molecular profiling of cancer tissues, familial cancer and pharmacogenomics. She is also the Sydney Cancer Partners Clinical and Strategic Partnerships Lead. 

For more information and to register, click here